Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood

[1]  L. Pachman,et al.  Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.

[2]  A. Paller,et al.  Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.

[3]  Michel Fischbach,et al.  The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. , 2008, Arthritis and rheumatism.

[4]  Honglin Li,et al.  Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease. , 2007, Clinical immunology.

[5]  L. Miles,et al.  Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. , 2007, Arthritis and rheumatism.

[6]  S. Marie,et al.  International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. , 2007, Arthritis and rheumatism.

[7]  M. Cooper,et al.  Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients. , 2007, Arthritis and rheumatism.

[8]  C. Weinberg,et al.  Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures. , 2007, Arthritis and rheumatism.

[9]  P. Riley,et al.  Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores. , 2007, Rheumatology.

[10]  B. Feldman,et al.  Inflammatory myopathies in children. , 2007, Pediatric clinics of North America.

[11]  D. Kleiner,et al.  Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy. , 2007, Arthritis and rheumatism.

[12]  C. Opava,et al.  Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. , 2007, Arthritis and rheumatism.

[13]  A. Dietz,et al.  Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. , 2007, Arthritis and rheumatism.

[14]  W. Ollier,et al.  The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis , 2007, Annals of the rheumatic diseases.

[15]  C. Langman,et al.  RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis. , 2007, Arthritis and rheumatism.

[16]  L. Rider.  The heterogeneity of juvenile myositis. , 2007, Autoimmunity reviews.

[17]  B. Feldman,et al.  Childhood acquired lipodystrophy: a retrospective study. , 2006, Journal of the American Academy of Dermatology.

[18]  Sharon Adams,et al.  Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. , 2006, Arthritis and rheumatism.

[19]  J. Sibilia,et al.  Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. , 2006, Joint, bone, spine : revue du rhumatisme.

[20]  P. García,et al.  Eficacia de tacrolimus (FK-506) en el tratamiento de las formas graves de dermatomiositis infantil: estudio de 6 casos , 2006 .

[21]  I. Targoff,et al.  A novel autoantibody to a 155-kd protein is associated with dermatomyositis. , 2006, Arthritis and rheumatism.

[22]  L. Wedderburn,et al.  The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr. , 2006, Rheumatology.

[23]  S. Stock,et al.  Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. , 2006, Arthritis and rheumatism.

[24]  L. Pachman,et al.  MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement. , 2006, Clinical immunology.

[25]  M. Covelli,et al.  Use of etanercept in the treatment of dermatomyositis: a case series. , 2006, The Journal of rheumatology.

[26]  S. Verma,et al.  Study of subcutaneous fat in children with juvenile dermatomyositis. , 2006, Arthritis and rheumatism.

[27]  B. Feldman,et al.  An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). , 2006, Rheumatology.

[28]  I. Lundberg,et al.  Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis , 2006, Annals of the rheumatic diseases.

[29]  K. Gruis,et al.  Pediatric macrophagic myofasciitis associated with motor delay. , 2006, Clinical neuropathology.

[30]  N. Romero,et al.  CAPN3 mutations in patients with idiopathic eosinophilic myositis , 2006 .

[31]  M. Weinblatt,et al.  Rituximab as therapy for refractory polymyositis and dermatomyositis. , 2006, The Journal of rheumatology.

[32]  M. Carrington,et al.  Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies , 2006, Medicine.

[33]  S. Marie,et al.  Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis. , 2006, Autoimmunity reviews.

[34]  M. Garami,et al.  National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary—Clinical characteristics and disease course of 44 patients with juvenile dermatomyositis , 2006, Autoimmunity.

[35]  B. Feldman,et al.  Long-term outcomes in juvenile dermatomyositis: How did we get here and where are we going? , 2005, Current rheumatology reports.

[36]  K. Brown,et al.  Parvovirus B19 and onset of juvenile dermatomyositis. , 2005, JAMA.

[37]  J. García-Peñas,et al.  Macrophagic myofasciitis in childhood: a controversial entity. , 2005, Pediatric neurology.

[38]  R. Schneider,et al.  The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. , 2005, Arthritis and rheumatism.

[39]  F. Ingegnoli,et al.  Capillaroscopic observations in childhood rheumatic diseases and healthy controls. , 2005, Clinical and experimental rheumatology.

[40]  B. Feldman,et al.  International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. , 2005, Arthritis and rheumatism.

[41]  P. Woo,et al.  Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis. , 2005, Arthritis and rheumatism.

[42]  E. Hoffman,et al.  Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. , 2005, Arthritis and rheumatism.

[43]  A. Dyer,et al.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. , 2005, Arthritis and rheumatism.

[44]  B. Feldman,et al.  Inflammatory myopathies in children. , 2005, Rheumatic diseases clinics of North America.

[45]  R. Petty,et al.  Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. , 2005, The Journal of rheumatology.

[46]  T. Levine.  Rituximab in the treatment of dermatomyositis: an open-label pilot study. , 2005, Arthritis and rheumatism.

[47]  Janice L Holton,et al.  Is it really myositis? A consideration of the differential diagnosis , 2004, Current opinion in rheumatology.

[48]  M. Caproni,et al.  Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis , 2004, The British journal of dermatology.

[49]  A. Dyer,et al.  Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. , 2004, The Journal of rheumatology.

[50]  P. Lachenbruch,et al.  International consensus on preliminary definitions of improvement in adult and juvenile myositis. , 2004, Arthritis and rheumatism.

[51]  P Woo,et al.  Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. , 2004, Rheumatology.

[52]  C. Ober,et al.  Does HLA-Dependent Chimerism Underlie the Pathogenesis of Juvenile Dermatomyositis?1 , 2004, The Journal of Immunology.

[53]  P. Woo,et al.  Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. , 2004, Rheumatology.

[54]  R. Sontheimer.  A portable digital microphotography unit for rapid documentation of periungual nailfold capillary changes in autoimmune connective tissue diseases. , 2004, The Journal of rheumatology.

[55]  J. Holton,et al.  MHC Class I overexpression on muscles in early juvenile dermatomyositis. , 2004, The Journal of rheumatology.

[56]  J. Jorizzo,et al.  Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study , 2004, The Journal of dermatological treatment.

[57]  G. Borgulya,et al.  Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features: A Longitudinal Study of 162 Cases , 2004, Medicine.

[58]  R. Hohlfeld,et al.  Polymyositis and dermatomyositis , 2003, The Lancet.

[59]  A. Dyer,et al.  US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. , 2003, Arthritis and rheumatism.

[60]  M. Netea,et al.  Successful Treatment of Dermatomyositis and Polymyositis with Anti-Tumor-Necrosis-Factor-Alpha: Preliminary Observations , 2003, European Neurology.

[61]  P. Bacon,et al.  Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study , 2003, Annals of the rheumatic diseases.

[62]  C. Berry,et al.  Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. , 2002, Arthritis and rheumatism.

[63]  B. Feldman,et al.  Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. , 2002, Rheumatic diseases clinics of North America.

[64]  L. Rider.  Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies. , 2002, Rheumatic diseases clinics of North America.

[65]  S. Ytterberg,et al.  Genetic and environmental risk factors for idiopathic inflammatory myopathies. , 2002, Rheumatic diseases clinics of North America.

[66]  Eric P. Hoffman,et al.  Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis1 , 2002, The Journal of Immunology.

[67]  L. Klareskog,et al.  Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. , 2002, Arthritis and rheumatism.

[68]  L. Rider,et al.  Decreased aerobic capacity in children with juvenile dermatomyositis. , 2002, Arthritis and rheumatism.

[69]  R. El-Azhary,et al.  Amyopathic dermatomyositis: retrospective review of 37 cases. , 2002, Journal of the American Academy of Dermatology.

[70]  D. Isenberg,et al.  Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. , 2001, Rheumatology.

[71]  L. Rider,et al.  Juvenile dermatomyositis presenting with anasarca: A possible indicator of severe disease activity. , 2001, The Journal of pediatrics.

[72]  R. Petty,et al.  Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities. , 2001, The Journal of rheumatology.

[73]  A. Reed,et al.  Chimerism in children with juvenile dermatomyositis , 2000, The Lancet.

[74]  F. Miller,et al.  Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies , 2000, The Lancet.

[75]  L. Pachman,et al.  The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis. , 2000, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[76]  R. Schneider,et al.  Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. , 2000, The Journal of rheumatology.

[77]  L. Pachman,et al.  TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications , 2000 .

[78]  A. Kimball,et al.  Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. , 2000, Arthritis and rheumatism.

[79]  P. Dent,et al.  Juvenile amyopathic dermatomyositis: results of a case finding descriptive survey. , 2000, The Journal of rheumatology.

[80]  S. Jimenez,et al.  Polymorphisms in the IL‐1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies , 2000, Clinical and experimental immunology.

[81]  N. Kamatani,et al.  Increased CD40 Expression on Muscle Cells of Polymyositis and Dermatomyositis: Role of CD40-CD40 Ligand Interaction in IL-6, IL-8, IL-15, and Monocyte Chemoattractant Protein-1 Production1 , 2000, The Journal of Immunology.

[82]  B. Feldman,et al.  Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. , 2000, Arthritis and rheumatism.

[83]  G. Cooper,et al.  The role of genetic factors in autoimmune disease: implications for environmental research. , 1999, Environmental health perspectives.

[84]  J. Malley,et al.  Juvenile idiopathic inflammatory myopathy: exercise-induced changes in muscle at short inversion time inversion-recovery MR imaging. , 1998, Radiology.

[85]  Juliette C. Stefanski,et al.  Abdominal Pain in a Girl with Juvenile Dermatomyositis , 1998, Clinical pediatrics.

[86]  A. Dyer,et al.  Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. , 1998, The Journal of rheumatology.

[87]  A. Reiff,et al.  Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. , 1997, The Journal of rheumatology.

[88]  A. Dyer,et al.  New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[89]  F. Miller,et al.  Classification and treatment of the juvenile idiopathic inflammatory myopathies. , 1997, Rheumatic diseases clinics of North America.

[90]  Y. Koike,et al.  Characteristics of juvenile dermatomyositis in Japan , 1997, Acta paediatrica Japonica : Overseas edition.

[91]  T. Crawford,et al.  Congenital muscular dystrophy with primary laminin α2 (merosin) deficiency presenting as inflammatory myopathy , 1996 .

[92]  B. Feldman,et al.  Where's the evidence? Putting clinical science into pediatric rheumatology. , 1996, The Journal of rheumatology.

[93]  M. Christensen,et al.  Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. , 1995, Arthritis and rheumatism.

[94]  L. Pachman.  Juvenile Dermatomyositis: Pathophysiology and Disease Expression , 1995 .

[95]  D. Symmons,et al.  The incidence of juvenile dermatomyositis: results from a nation-wide study. , 1995, British journal of rheumatology.

[96]  V. Dubowitz,et al.  Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases. , 1995, Archives of disease in childhood.

[97]  J. Dambrosia,et al.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. , 1993, The New England journal of medicine.

[98]  T. Chenevert,et al.  MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. , 1993, AJR. American journal of roentgenology.

[99]  M. Ferrarini,et al.  Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. , 1993, Clinical and experimental rheumatology.

[100]  L. Tucker,et al.  Methotrexate treatment of recalcitrant childhood dermatomyositis. , 1992, Arthritis and rheumatism.

[101]  S. Douglas,et al.  Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect. , 1992, Annals of the rheumatic diseases.

[102]  C. Ober,et al.  Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501. , 1991, Human immunology.

[103]  M. Dalakas,et al.  A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups , 1991, Medicine.

[104]  E. Silverman,et al.  Treatment of dermatomyositis with intravenous gammaglobulin. , 1991, The American journal of medicine.

[105]  Olson Ny,et al.  Adjunctive use of hydroxychloroquine in childhood dermatomyositis. , 1989 .

[106]  V. Dubowitz,et al.  CYCLOSPORIN IN JUVENILE DERMATOMYOSITIS , 1989, The Lancet.

[107]  E. Gelfand,et al.  Reversal of chronic polymyositis following intravenous immune serum globulin therapy. , 1987, JAMA.

[108]  V. Dubowitz,et al.  DERMATOMYOSITIS, POLYMYOSITIS, AND COXSACKIE-B-VIRUS INFECTION , 1987, The Lancet.

[109]  J. Friedman,et al.  Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. , 1986, Arthritis and rheumatism.

[110]  A. Spiro.  Childhood Dermatomyositis and Polymyositis , 1984, Pediatrics In Review.

[111]  B. Bernstein,et al.  Course of treated juvenile dermatomyositis. , 1984, The Journal of pediatrics.

[112]  C. Blane,et al.  Patterns of calcification in childhood dermatomyositis. , 1984, AJR. American journal of roentgenology.

[113]  C. Blane,et al.  Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. , 1983, The Journal of pediatrics.

[114]  A. Masi,et al.  Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. , 1982, The Journal of rheumatology.

[115]  W. Crowe,et al.  Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. , 1982, Arthritis and rheumatism.

[116]  E. Braunstein,et al.  Pneumatosis intestinalis in dermatomyositis. , 1980, The British journal of radiology.

[117]  C. Catricalà,et al.  Dermatomyositis‐like syndrome due to toxoplasma , 1979, The British journal of dermatology.

[118]  H. Paulus,et al.  Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone. , 1979, American journal of diseases of children.

[119]  O. Jonasson,et al.  INCREASED FREQUENCY OF HLA-B8 IN JUVENILE DERMATOMYOSITIS , 1977, The Lancet.

[120]  R. Petty,et al.  Dermatomyositis in the pediatric patient. , 1977, Arthritis and rheumatism.

[121]  Miller Rd,et al.  Persistance of activity in dermatomyositis of childhood. , 1977 .

[122]  J. Brody,et al.  Childhood polymyositis: a case-control study. , 1976, American journal of epidemiology.

[123]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[124]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[125]  F. Oechsli.  Letter: Oral contraception and sex ratio at birth. , 1974, Lancet.

[126]  J. Miller,et al.  Late progression in dermatomyositis in childhood. , 1973, Jornal de Pediatria.

[127]  M. Victor,et al.  DERMATOMYOSITIS (SYSTEMIC ANGIOPATHY) OF CHILDHOOD , 1966, Medicine.

[128]  P. Gregersen,et al.  An Interferon Signature in the Peripheral Blood of Dermatomyositis Patients is Associated with Disease Activity , 2007, Molecular medicine.

[129]  F. Miller,et al.  Myositis and You: A Guide to Juvenile Dermatomyositis for Patients, Families, and Healthcare Providers , 2007 .

[130]  M. Fujimoto,et al.  Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. , 2007, Rheumatology.

[131]  J. Callen,et al.  Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. , 2006, Archives of dermatology.

[132]  A. Martín Nalda,et al.  [Efficacy of tacrolimus (FK-506) in the treatment of recalcitrant juvenile dermatomyositis: study of 6 cases]. , 2006, Medicina clinica.

[133]  S. Shinjo,et al.  Spontaneous pneumomediastinum and dermatomyositis may be a not so rare association: report of a case and review of the literature , 2005, Clinical Rheumatology.

[134]  G. Serratrice,et al.  International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. , 2004, Rheumatology.

[135]  S. Al‐Mayouf,et al.  Efficacy of Early Treatment of Severe Juvenile Dermatomyositis with Intravenous Methylprednisolone and Methotrexate , 2000, Clinical Rheumatology.

[136]  L. Pachman,et al.  TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. , 2000, Arthritis and rheumatism.

[137]  L. Pachman.  Pathophysiology and Disease Expression , 1995 .

[138]  A. Chalmers,et al.  Juvenile dermatomyositis: medical, social and economic status in adulthood. , 1982, Canadian Medical Association journal.

[139]  T. Bunch.  Prednisone and azathioprine for polymyositis: long-term followup. , 1981, Arthritis and rheumatism.